Mark Maurer is a reporter on The Wall Street Journal’s CFO Journal team. Based in New York, he writes about corporate finance, accounting, auditing and regulation of companies. Before joining ...

Despite making significant gains today, Dogecoin is still down 16.74% over the week, with its current price of $0.3385 ...

The consensus mark for fiscal 2025 EPS has moved north by 2 cents over the past 30 days. Seven of the eight brokers covering ...

Stocks closed higher on Wall Street at the start of a holiday-shortened week. The S&P 500 rose 0.7% Monday. Several big ...

Mark Maremont is a senior editor with The Wall Street Journal. He focuses on investigative reporting, particularly in the business, finance and political spheres, and is based in the Journal's ...

Mark Wall and Shónagh Ní Raghallaigh are elected in Kildare South Mark Wall and Shónagh Ní Raghallaigh are elected in Kildare South Join the Irish Independent WhatsApp channel Stay up to date ...

Wall Street pointed toward gains early as markets try to claw back losses from a rare bumpy week. Futures for the S&P 500 ...

Stock-split euphoria took over Wall Street in 2024, and two brand-name companies could continue this trend in the new year.

Bring it on Yeah The Wall Yeah, yeah, yeah, yo, yo ...

There are now nine companies in the trillion-dollar club. If this bull market continues, more could join them. None of these ...

Complicating Amgen’s chances of competing further, both Novo and Lilly have succesor obesity drugs in Phase 3 development that, if successful in the clinic, could reach the market before MariTide.